Skip to main content
All lobbying filings

Consumer Healthcare Products Association

Consumer Healthcare Products Association filed a Q2 report for Consumer Healthcare Products Association on July 17, 2025, reporting $196,425 in lobbying income.

Lobbying for Consumer Healthcare Products Association

As filed: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION for CONSUMER HEALTHCARE PRODUCTS ASSOCIATION.

All filings by Consumer Healthcare Products Association · Everything Consumer Healthcare Products Association has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 17, 2025
Income
$196,425
What the client paid this registrant for the period.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 6

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 5
Health Issues

H.R.4273 - To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user fee program for over-the-counter monograph drugs, and for other purposes. S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Legislative language on General Recognition of Safety and Effectiveness

Pharmacy

- The Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act - Fluoride and fluoridated water - Additive Ingredients in Drug Products - Over-the-Counter Tests - Pediatric Labeling

Consumer Issues/Safety/Products

- The SHOP SAFE Act - Advocacy to protect funding for the Office of the Intellectual Property Enforcement Coordinator (IPEC) and to advocate for an IPEC appointment before the end of the year.

Taxation/Internal Revenue Code

- H.R. 1219, Oral Health Products Inclusion Act - Pharmaceutical Tariffs - HSA/FSA Treatment for Dietary Supplements - Modernization of the Dietary Safety, Health and Education Act (DSHEA) - Regulation of Cannabidiol (CBD)

Manufacturing

- Pharmaceutical Tariffs

 Bills named in this filing 6
  • H.R. 4273
    Over-the-Counter Monograph Drug User Fee Amendments
  • S. 355
    FDA Modernization Act 3.0
  • H.R. 2821
    FDA Modernization Act 3.0
  • H.R. 3686
    SAFE Sunscreen Standards Act
  • H.R. 1
    One Big Beautiful Bill Act
  • H.R. 1219
    Oral Health Products Inclusion Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem